Skip to main content
. 2007 Aug 15;81(21):11658–11668. doi: 10.1128/JVI.00995-07

TABLE 1.

Detected epitopesa

Patient Epitope sequence Variant sequence H77 position HLA restrictionb
BR111 NEGCGWAGW 88-96 B44
LLALLSCLTV 178-187 A2
CINGVCWTV 1073-1081 A2
KLVALGVNAV 1406-1415 A2
ILAGYGAGV 1851-1859 A2
VLSDFKTWL 1987-1995 A2
RQVGDFHYV 2094-2102 A2
ALYDVVSKL 2594-2602 A2
BR554 YLLPRRGPRL 35-44 A2
YRLWHYPCTI 613-622 Cw7
LYGMWPLLL 790-798 Cw7
CINGVCWTV 1073-1081 A2
HAVGIFRAA HVVGIFRAA 1175-1183 A2
LFFNILGGWV 1807-1816 A2
VLSDFKTWL 1987-1995 A2
SLLRHHNLVYSTTSRSA SLLRNHNLVYSTTSRSA* 2449-2465
THFFSVLIARDQ THLFSVLMARDQ* 2847-2858
03-32 NEGCGWAGW 88-96 (B44)
LLALLSCLTV 178-187 (A2)
NASRCWVAM 234-242 B35
RLADFAQGW 461-469 (B53)
NTRPPLGNWF 541-550 (B57)
YRLWHYPCTI 613-622 Cw7
FYGMWPLLL 790-798 Cw7
LSPYYKRYISW 831-841 (A25)
HPTLVFDITKL 881-889
AVFGPLWIL 894-902
CINGVCWTV 1073-1081 (A2)
VTRHADVIPV 1133-1142 (A2)
HAVGIFRAA 1175-1183 (A2/A68)
ATLGFGAYMSKA 1260-1271 A3
GVDPNVRTGVRT 1273-1284
YDIIICDECHSTDATSIL 1310-1327 (B38)
HPNIEEVAL HSNIEEVAL* 1359-1367 B35
ATDALMTGF 1436-1444 A1
CVTQTVDFSLDPTFTIETTTL 1457-1477
TLTHPITK 1636-1643 B8
LPYIEQGMML 1715-1724 B35
VITPVVQTNW 1745-1754
LTTSQTLLF 1801-1809 (B57)
HRFAPPCKPLLR 2131-2142 (B27)
EPEPDVAVL EPEPDVAW* 2163-2171 B35
LGVPPLRAWR 2912-2921 (B57)
a

Epitope sequences and their positions according to the H77 reference sequence are indicated. Two peptide epitopes specifically synthesized according to the wild-type viral sequence are printed in italics in column 2. Variant peptides that resulted in reduced antigen recognition by ELISPOT titration assay are marked with an asterisk. The specific difference is indicated in boldface. No epitopes were detected for patient BR1427.

b

Known HLA restrictions for each epitope are given. Described HLA restrictions not matching our patients’ HLA types are given in parentheses.